Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Tumors”

272 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 272 results

Not applicableLooking for participantsNCT04151342
What this trial is testing

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

Who this might be right for
CancerMalignancies MultipleMalignant Solid Tumor+7 more
University Health Network, Toronto 5,500
Testing effectiveness (Phase 2)Study completedNCT01755195
What this trial is testing

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
Refractory Soft Tissue Sarcomas
National Cancer Institute (NCI) 55
Not applicableEnded earlyNCT03472807
What this trial is testing

EXOme Rare Cancers in Children (EXOCARE)

Who this might be right for
Predisposition, GeneticCancer ChildhoodDevelopment Delay
University Hospital, Angers 169
Testing effectiveness (Phase 2)Study completedNCT04551521
What this trial is testing

CRAFT: The NCT-PMO-1602 Phase II Trial

Who this might be right for
Metastatic or Locally Advanced Malignancies
German Cancer Research Center 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053
What this trial is testing

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Who this might be right for
Rare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Testing effectiveness (Phase 2)Looking for participantsNCT07089992
What this trial is testing

Pembrolizumab in People With Ultra-Rare Sarcomas

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 32
Not applicableActive Not RecruitingNCT04358107
What this trial is testing

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 1,000
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Not applicableUnknownNCT05411276
What this trial is testing

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

Who this might be right for
HER2 Mutant Non-small Cell Lung Cancer
Beijing Chest Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Not applicableUnknownNCT06174857
What this trial is testing

Efficacy of Osimertinib in Patients With Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03840772
What this trial is testing

Eribulin in Advanced Solitary Fibrous Tumor

Who this might be right for
Solitary Fibrous Tumor
Italian Sarcoma Group 16
Not applicableLooking for participantsNCT05852522
What this trial is testing

Molecularly Aided Stratification for Tumor Eradication Research

Who this might be right for
Rare CancersMultiomics
German Cancer Research Center 10,000
Not applicableStudy completedNCT05199402
What this trial is testing

Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases

Who this might be right for
Tuberous SclerosisEpilepsy
Imagine Institute 10
Testing effectiveness (Phase 2)Looking for participantsNCT05800340
What this trial is testing

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Who this might be right for
Non-Small Cell Lung CancerRET Driver MutationBRAF V600 Mutation+3 more
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05024968
What this trial is testing

Sintilimab in Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
M.D. Anderson Cancer Center 10
Not applicableLooking for participantsNCT05203250
What this trial is testing

Longitudinal Registry Including Patients Treated With Heavy Particles

Who this might be right for
CancerOncologyRadiation Exposure+3 more
CNAO National Center of Oncological Hadrontherapy 3,000
Not applicableLooking for participantsNCT07731880
What this trial is testing

Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers

Who this might be right for
Malignant Female Reproductive System NeoplasmMetastatic Malignant Female Reproductive System NeoplasmUnresectable Malignant Female Reproductive System Neoplasm
Fred Hutchinson Cancer Center 30
Not applicableStudy completedNCT00005654
What this trial is testing

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Who this might be right for
HyperinsulinismPolycystic Ovary Syndrome
National Center for Research Resources (NCRR) 88
Testing effectiveness (Phase 2)Looking for participantsNCT04423185
What this trial is testing

PLATFORM Study of Precision Medicine for Rare Tumors

Who this might be right for
Rare Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 770
Next Page